FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/02/017657 [Registered on: 14/02/2019] Trial Registered Prospectively
Last Modified On: 02/12/2019
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   DRUG RESISTANCE IN FUNGAL SKIN INFECTIONS 
Scientific Title of Study   ELUCIDATING THE DERMATOPHYTE SPECTRUM THROUGH RAPID MULTIPLEX PCR AND DETECTION OF ANTIFUNGAL DRUG RESISTANCE CAUSED BY MUTATIONS IN SQUALENE EPOXIDASE AND 14-ALFA DEMETHYLASE GENE 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jyothi Jayaraman 
Designation  Senior Resident 
Affiliation  Father Muller medical college 
Address  Department of dermatology, Father Muller medical college hospital, kankanady, Mangaluru

Dakshina Kannada
KARNATAKA
575002
India 
Phone  8861631648  
Fax    
Email  derm.jyo@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Meghashree G 
Designation  PG Resident 
Affiliation  Father Muller medical college 
Address  Department of dermatology, Father Muller medical college hospital, kankanady, Mangaluru

Dakshina Kannada
KARNATAKA
575002
India 
Phone  9741639736  
Fax    
Email  megha91leo@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Meghashree G 
Designation  PG Resident 
Affiliation  Father Muller medical college 
Address  Department of dermatology, Father Muller medical college hospital, kankanady, Mangaluru

Dakshina Kannada
KARNATAKA
575002
India 
Phone  9741639736  
Fax    
Email  megha91leo@gmail.com  
 
Source of Monetary or Material Support  
IADVL (Indian association of dermatology venerology and leprology) research grant 2018 IADVL headquarters, 4772-73 pvt no., T-3 & T-4, 3rd floor, 23 bharat ram road, darya ganj, new delhi- 110002 
 
Primary Sponsor  
Name  IADVL 
Address  Dr. Umashankar Nagaraju Honorary Secretary General Indian Association of Dermatologists Venereologists & Leprologists IADVL National Headquarters 4772-73 Pvt No.T-3 & T-4 3rd Floor 23 Bharat Ram Road Darya Ganj New Delhi-110002. 
Type of Sponsor  Other [INDIAN ASSOCIATION OF DERMATOLOGIST VENEROLOGIST AND LEPROLOGIST] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
dr meghashree g  father muller medical college   Department of dermatology, room no 65, Father Muller medical college hospital,kankanady,mangalore,575002
Dakshina Kannada
KARNATAKA 
9741639736

megha91leo@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Father Muller medical college institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L088||Other specified local infections of the skin and subcutaneous tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1.All the patients above 18 years of age with suspected dermatophytic skin infection willing to give consent will be included in the study 
 
ExclusionCriteria 
Details  below 18 years
those unwilling to give consent 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Identification of species of dermatopytes and drug resistance in dermatophytic skin infection by rapid methods1  2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
NONE  NONE 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/03/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details
Modification(s)  
References 1. Surendran K, Bhat RM, Boloor R, Nandakishore B, Sukumar D. 2014. A clinical and mycological study of dermatophytic infections. Indian J Dermatol . 59:262-7. 2.Dogra S, Uprety S. 2016. The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive? Indian Dermatol Online J 7:73-6. 3. Gupta AK, Kohli Y. 2003. Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy. Dermatology 207:375–380. 4. Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. 2003. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 47:82–6. 5.Osborne CS, Leitner I, Favre B, Neil S, Ryder NS. 2005. Amino Acid Substitution in Trichophyton rubrum Squalene Epoxidase Associated with Resistance to Terbinafine. Antimicrob Agents Chemother 49:2840–4.  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
All clinically identified cases of dermatophyte skin infections not on treatment with topical and/or systemic antifungal from 2 weeks prior will be included in the study. Skin scrapings will be collected using no.15 sterile blade on the Dermatophyte Test Media and KOH mount will be done.  The media that shows growth of filamentous fungi will be then subcultured on to SDA for species identification. 
A portion of the skin scrapings (~100 mg) will be aliquoted for DNA extraction. Fungal DNA will be extracted from the skin scraping . The extracted DNA will be quantified using a
Nanodrop UV spectrophotometer. Conventional PCR and Species specific RT PCR will be performed . It is performed for live fungi where protein synthesis is taking place. PCR products will be resolved by horizontal gel electrophoresis and results will be analyzed using the gel documentation system. The amplicons will be purified and then sequenced. Sequences will be analyzed using bioinformatics tools to identify
species and determine the clonal nature of the fungi detected. Squalene epoxidase gene will be amplified using three sets of primers. The sequences will then be analyzed for point mutations using bioinformatics tools. Primers for CYP51 gene which codes for 14α-demethylase will be designed. Cycling conditions will be optimized.This target gene will be amplified and sequenced. 
The sequences will then be analyzed for mutations using bioinformatics tools. 
 
Close